{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:27:43Z","timestamp":1792528063803,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T00:00:00Z","timestamp":1406246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/npp.2014.188","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T10:57:49Z","timestamp":1406285869000},"page":"421-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["Compulsive-Like Responding for Opioid Analgesics in Rats with Extended Access"],"prefix":"10.1038","volume":"40","author":[{"given":"Carrie L","family":"Wade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro F","family":"Vendruscolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel E","family":"Schlosburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,25]]},"reference":[{"key":"BFnpp2014188_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nn872","volume":"5","author":"SH Ahmed","year":"2002","unstructured":"Ahmed SH, Kenny PJ, Koob GF, Markou A (2002). Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci 5: 625\u2013626.","journal-title":"Nat Neurosci"},{"key":"BFnpp2014188_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0893-133X(99)00133-5","volume":"22","author":"SH Ahmed","year":"2000","unstructured":"Ahmed SH, Walker JR, Koob GF (2000). Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22: 413\u2013421.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2014188_CR3","unstructured":"American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders 5th edn, American Psychiatric Press: Washington, DC, USA; (2013)."},{"key":"BFnpp2014188_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/npp.2012.261","volume":"38","author":"E Barbier","year":"2013","unstructured":"Barbier E, Vendruscolo LF, Schlosburg JE, Edwards S, Juergens N, Park PE et al (2013). The NK1 receptor antagonist l822429 reduces heroin reinforcement. Neuropsychopharmacology 38: 976\u2013984.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2014188_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1037\/1064-1297.12.3.163","volume":"12","author":"PM Beardsley","year":"2004","unstructured":"Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS (2004). Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys. Exp Clin Psychopharmacol 12: 163\u2013172.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp2014188_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jama.1985.03360010087032","volume":"254","author":"MA Bozarth","year":"1985","unstructured":"Bozarth MA, Wise RA (1985). Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA 254: 81\u201383.","journal-title":"JAMA"},{"key":"BFnpp2014188_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/jnc.12452","volume":"128","author":"ES Calipari","year":"2014","unstructured":"Calipari ES, Ferris MJ, Jones SR (2014). Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine. J Neurochem 128: 224\u2013232.","journal-title":"J Neurochem"},{"key":"BFnpp2014188_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/jpet.114.214262","volume":"350","author":"JR Cashman","year":"2014","unstructured":"Cashman JR, Azar MR (2014). Potent inhibition of alcohol self-administration in alcohol-preferring rats by a kappa-opioid receptor antagonist. J Pharmacol Exp Ther 350: 171\u2013180.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2014188_CR9","first-page":"1487","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention (2011). Vital signs: overdoses of prescription opioid pain relievers-: United States, 1999\u20132008. Morb Mortal Wkly Rep 60: 1487\u20131492.","journal-title":"Morb Mortal Wkly Rep"},{"key":"BFnpp2014188_CR10","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/sj.npp.1301008","volume":"31","author":"SA Chen","year":"2006","unstructured":"Chen SA, O'Dell LE, Hoefer ME, Greenwell TN, Zorrilla EP, Koob GF (2006). Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology 31: 2692\u20132707.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2014188_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0091-3057(78)90370-2","volume":"9","author":"FC Colpaert","year":"1978","unstructured":"Colpaert FC (1978). Discriminative stimulus properties of narcotic analgesic drugs. Pharmacol Biochem Behav 9: 863\u2013887.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2014188_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-61779-458-2_2","volume":"829","author":"S Edwards","year":"2012","unstructured":"Edwards S, Koob GF (2012). Experimental psychiatric illness and drug abuse models: from human to animal, an overview. Methods Mol Biol 829: 31\u201348.","journal-title":"Methods Mol Biol"},{"key":"BFnpp2014188_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-3565(25)10743-X","volume":"262","author":"B Frances","year":"1992","unstructured":"Frances B, Gout R, Monsarrat B, Cros J, Zajac JM (1992). Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. J Pharmacol Exp Ther 262: 25\u201331.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2014188_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.134.3483.943","volume":"134","author":"W Hodos","year":"1961","unstructured":"Hodos W (1961). Progressive ratio as a measure of reward strength. Science 134: 943\u2013944.","journal-title":"Science"},{"key":"BFnpp2014188_CR15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","volume":"297","author":"P Huang","year":"2001","unstructured":"Huang P, Kehner GB, Cowan A, Liu-Chen LY (2001). Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. J Pharmacol Exp Ther 297: 688\u2013695.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2014188_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1254\/jjp.40.95","volume":"40","author":"M Kajiwara","year":"1986","unstructured":"Kajiwara M, Aoki K, Ishii K, Numata H, Matsumiya T, Oka T (1986). Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations. Japanese journal of pharmacology 40: 95\u2013101.","journal-title":"Japanese journal of pharmacology"},{"key":"BFnpp2014188_CR17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1124\/jpet.301.2.698","volume":"301","author":"MC Ko","year":"2002","unstructured":"Ko MC, Terner J, Hursh S, Woods JH, Winger G (2002). Relative reinforcing effects of three opioids with different durations of action. J Pharmacol Exp Ther 301: 698\u2013704.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"BFnpp2014188_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuropharm.2008.07.043","volume":"56","author":"GF Koob","year":"2009","unstructured":"Koob GF (2009). Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 56 (Suppl 1): 18\u201331.","journal-title":"Neuropharmacology"},{"key":"BFnpp2014188_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neubiorev.2003.11.007","volume":"27","author":"GF Koob","year":"2004","unstructured":"Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A et al (2004). Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27: 739\u2013749.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2014188_CR20","first-page":"370","volume":"76b","author":"GF Koob","year":"2013","unstructured":"Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE et al (2013). Addiction as a stress surfeit disorder. Neuropharmacology 76b: 370\u2013382.","journal-title":"Neuropharmacology"},{"key":"BFnpp2014188_CR21","volume-title":"Neurobiology of Addiction","author":"GF Koob","year":"2006","unstructured":"Koob GF, Le Moal M (2006) Neurobiology of Addiction. Academic Press: London, UK."},{"key":"BFnpp2014188_CR22","doi-asserted-by":"publisher","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","volume":"23","author":"EB Margolis","year":"2003","unstructured":"Margolis EB, Hjelmstad GO, Bonci A, Fields HL (2003). Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 23: 9981\u20139986.","journal-title":"J Neurosci"},{"key":"BFnpp2014188_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1037\/a0013597","volume":"16","author":"TJ Martin","year":"2008","unstructured":"Martin TJ, Ewan E (2008). Chronic pain alters drug self-administration: implications for addiction and pain mechanisms. Exp Clin Psychopharmacol 16: 357\u2013366.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp2014188_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/00000542-200702000-00020","volume":"106","author":"TJ Martin","year":"2007","unstructured":"Martin TJ, Kim SA, Buechler NL, Porreca F, Eisenach JC (2007). Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology 106: 312\u2013322.","journal-title":"Anesthesiology"},{"key":"BFnpp2014188_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0376-8716(88)90053-1","volume":"21","author":"NK Mello","year":"1988","unstructured":"Mello NK, Lukas SE, Bree MP, Mendelson JH (1988). Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys. Drug Alcohol Depend 21: 81\u201397.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2014188_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/sj.npp.1301319","volume":"32","author":"NK Mello","year":"2007","unstructured":"Mello NK, Negus SS (2007). Effects of d-amphetamine and buprenorphine combinations on speedball (cocaine+heroin) self-administration by rhesus monkeys. Neuropsychopharmacology 32: 1985\u20131994.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2014188_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(96)00322-3","volume":"75","author":"NP Murphy","year":"1996","unstructured":"Murphy NP, Ly HT, Maidment NT (1996). Intracerebroventricular orphanin FQ\/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience 75: 1\u20134.","journal-title":"Neuroscience"},{"key":"BFnpp2014188_CR28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1124\/jpet.105.095380","volume":"317","author":"SS Negus","year":"2006","unstructured":"Negus SS (2006). Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther 317: 711\u2013723.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2014188_CR29","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1523\/JNEUROSCI.20-11-04226.2000","volume":"20","author":"PV Piazza","year":"2000","unstructured":"Piazza PV, Deroche-Gamonent V, Rouge-Pont F, Le Moal M (2000). Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J Neurosci 20: 4226\u20134232.","journal-title":"J Neurosci"},{"key":"BFnpp2014188_CR30","volume-title":"Methods of Behavior Analysis in Neuroscience","author":"AJ Prus","year":"2009","unstructured":"Prus AJ, James JR, Rosecrans JA (2009). Conditioned place preference. In: Buccafusco JJ, (ed). Methods of Behavior Analysis in Neuroscience 2nd edn, CRC Press: Boca Raton, FL, USA."},{"key":"BFnpp2014188_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF00439560","volume":"97","author":"DC Roberts","year":"1989","unstructured":"Roberts DC, Loh EA, Vickers G (1989). Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology (Berl) 97: 535\u2013538.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2014188_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/00008877-200011000-00005","volume":"11","author":"AB Sante","year":"2000","unstructured":"Sante AB, Nobre MJ, Brandao ML (2000). Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behav Pharmacol 11: 583\u2013589.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2014188_CR33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(25)21937-1","volume":"229","author":"HE Shannon","year":"1984","unstructured":"Shannon HE, Cone EJ, Gorodetzky CW (1984). Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone. J Pharmacol Exp Ther 229: 768\u2013774.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2014188_CR34","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on http:\/\/www.dasis.samhsa.gov\/webt\/quicklink\/US12.htm (2012). Drug Use and Health: National Findings (NSDUH Series H-34, DHHS publication no. SMA 08-4343). Office of Applied Statistics: Rockville, MD, USA, (2008)."},{"key":"BFnpp2014188_CR35","unstructured":"Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set. Substance Abuse and Mental Health Services Administration ( http:\/\/www.oas.samhsa.gov\/2k10\/230\/230PainRelvr2k10.htm ; accessed 22 May 2009). Office of Applied Studies: Rockville, MD, USA, (2012)."},{"key":"BFnpp2014188_CR36","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.pbb.2011.03.004","volume":"98","author":"LF Vendruscolo","year":"2011","unstructured":"Vendruscolo LF, Schlosburg JE, Misra KK, Chen SA, Greenwell TN, Koob GF (2011). Escalation patterns of varying periods of heroin access. Pharmacol Biochem Behav 98: 570\u2013574.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2014188_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","volume":"59","author":"DA Volpe","year":"2011","unstructured":"Volpe DA, McMahon Tobin GA, Mellon RD, Katki AG, Parker RJ, Colatsky T et al (2011). Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol 59: 385\u2013390.","journal-title":"Regul Toxicol Pharmacol"},{"key":"BFnpp2014188_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00213-009-1563-y","volume":"205L","author":"S Wee","year":"2009","unstructured":"Wee S, Orio L, Ghirmai S, Cashman JR, Koob GF (2009). Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology (Berl) 205L: 565\u2013575.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2014188_CR39","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th revision. World Health Organization: Geneva, Switzerland; (1992)."},{"key":"BFnpp2014188_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000103923","volume":"80","author":"G Zernig","year":"2007","unstructured":"Zernig G, Ahmed SH, Cardinal RN, Morgan D, Acquas E, Foltin RW et al (2007). Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 80: 65\u2013119.","journal-title":"Pharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2014188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2014188","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2014188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T23:09:48Z","timestamp":1746313788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2014188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,25]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFnpp2014188"],"URL":"https:\/\/doi.org\/10.1038\/npp.2014.188","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,25]]},"assertion":[{"value":"12 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}